Cargando…

Combined modality therapy in the adjuvant treatment of uterine serous carcinoma

Detalles Bibliográficos
Autores principales:	Block, Alec M., Small, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717218/ https://www.ncbi.nlm.nih.gov/pubmed/26768779 http://dx.doi.org/10.3802/jgo.2016.27.e13

Ejemplares similares

Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012)

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
por: Tate, Keisei, et al.
Publicado: (2018)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

BET inhibitors: Betting on improved outcomes in uterine serous carcinoma
por: Zeybek, Burak, et al.
Publicado: (2018)

Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
por: Arden, Jessica D., et al.
Publicado: (2020)

Treatment of early uterine sarcomas: disentangling adjuvant modalities
por: Zagouri, Flora, et al.
Publicado: (2009)

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
por: Gungorduk, Kemal, et al.
Publicado: (2015)

The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma
por: Cook, Andrew, et al.
Publicado: (2021)

Targeting Her2/neu in uterine serous carcinoma: A paradigm shift in management
por: Lopez, Salvatore, et al.
Publicado: (2018)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma – an anachronism?
por: Emons, Günter
Publicado: (2020)

The role of omentectomy in the surgical treatment of uterine serous carcinoma
por: Chen, Ming, et al.
Publicado: (2019)

Combined trastuzumab and radiation therapy for HER2-positive uterine serous carcinoma: A case report
por: Mao, SPH, et al.
Publicado: (2023)

Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Stage III uterine serous carcinoma: modern trends in multimodality treatment
por: Li, Jessie Y., et al.
Publicado: (2020)

Papillary Serous Carcinoma of the Uterine Cervix with Lung Metastasis
por: Khan, Maliha, et al.
Publicado: (2014)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Adrenal Metastasis from Uterine Papillary Serous Carcinoma
por: Lubana, Sandeep Singh, et al.
Publicado: (2016)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Improved survival of patients with hypermutation in uterine serous carcinoma
por: Santin, Alessandro D., et al.
Publicado: (2015)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone
por: Mahdi, Haider, et al.
Publicado: (2016)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
por: El-Sahwi, K, et al.
Publicado: (2010)

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2018)

Superior vena cava syndrome associated with uterine serous carcinoma
por: Laibangyang, Anya, et al.
Publicado: (2020)

Impact of positive cytology in uterine serous carcinoma: A reassessment
por: Corey, Logan, et al.
Publicado: (2021)

Uterine serous carcinoma: assessing association between genomics and patterns of metastasis
por: Alessandrino, Francesco, et al.
Publicado: (2023)

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma
por: Burkett, Wesley C., et al.
Publicado: (2023)

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report
por: Han, Chanhee, et al.
Publicado: (2018)

Cytologic Findings of Cervicovaginal Smears in Women with Uterine Papillary Serous Carcinoma
por: Park, Ji-Young, et al.
Publicado: (2005)

Breast metastases: A rare manifestation of advanced uterine serous carcinoma
por: McEachron, Jennifer, et al.
Publicado: (2019)

Correction: Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2021)

A 4-gene signature predicts prognosis of uterine serous carcinoma
por: Chen, Hui, et al.
Publicado: (2021)

Malignant Pleural Effusion Due to Uterine Serous Carcinoma: An Unusual Presentation
por: Wasifuddin, Mustafa, et al.
Publicado: (2023)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
por: Najjar, Omar, et al.
Publicado: (2020)

Aptamedicine: a new treatment modality in personalized cancer therapy
por: Vandghanooni, Somayeh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c4hq72o56bghdt316pqpgb5ttn